MENU
+Compare
CTKB
Stock ticker: NASDAQ
AS OF
Sep 5, 04:59 PM (EDT)
Price
$4.01
Change
+$0.03 (+0.75%)
Capitalization
506.35M

CTKB Cytek Biosciences Forecast, Technical & Fundamental Analysis

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches... Show more

CTKB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CTKB with price predictions
Sep 04, 2025

CTKB's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for CTKB moved out of overbought territory on August 08, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 instances where the indicator moved out of the overbought zone. In of the 16 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CTKB as a result. In of 58 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CTKB turned negative on August 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTKB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTKB advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 105 cases where CTKB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTKB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.341) is normal, around the industry mean (59.958). P/E Ratio (0.000) is within average values for comparable stocks, (37.886). CTKB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.671). CTKB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (2.616) is also within normal values, averaging (80.383).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTKB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
CTKB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CTKB is expected to report earnings to fall 87.50% to 0 cents per share on November 11

Cytek Biosciences CTKB Stock Earnings Reports
Q3'25
Est.
$0.00
Q2'25
Est.
$-0.04
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.01
Q3'24
Est.
$0.01
The last earnings report on August 06 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 317.06K shares outstanding, the current market capitalization sits at 506.35M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
47215 Lakeview Boulevard
Phone
+1 877 922-9835
Employees
676
Web
https://www.cytekbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CZMSX16.660.24
+1.46%
Multi-Manager Small Cap Eq Strat Inst
AMGOX23.650.33
+1.42%
Alger Mid Cap Growth I-2
PMYZX46.580.42
+0.91%
Putnam Core Equity Fund R
LCRIX23.670.15
+0.64%
Leuthold Core Investment Institutional
MSHPX15.44N/A
N/A
Morgan Stanley Inst Permanence R6

CTKB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CTKB has been loosely correlated with GMED. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CTKB jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
+1.02%
GMED - CTKB
48%
Loosely correlated
+2.53%
CRL - CTKB
46%
Loosely correlated
-0.01%
TMCI - CTKB
45%
Loosely correlated
-1.10%
LAB - CTKB
42%
Loosely correlated
N/A
MTD - CTKB
41%
Loosely correlated
+1.51%
More

Groups containing CTKB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
+1.02%
Medical/Nursing Services
industry (226 stocks)
31%
Poorly correlated
+0.21%
Health Services
industry (438 stocks)
30%
Poorly correlated
+0.20%